{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:27:53Z","timestamp":1790418473977,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.neuropharm.2005.08.011","type":"journal-article","created":{"date-parts":[[2005,9,22]],"date-time":"2005-09-22T11:21:12Z","timestamp":1127388072000},"page":"759-768","source":"Crossref","is-referenced-by-count":45,"title":["Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation"],"prefix":"10.1016","volume":"49","author":[{"given":"Balachandra K.","family":"Gorentla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne A.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2005.08.011_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2002.tb04154.x","article-title":"Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence","volume":"965","author":"Baumann","year":"2002","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib2","first-page":"150","article-title":"Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys","volume":"251","author":"Bergman","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1074\/jbc.274.2.889","article-title":"Regulation of \u03b3-aminobutyric acid (GABA) transporters by extracellular GABA","volume":"274","author":"Bernstein","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib4","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M501969200","article-title":"Endogenous and psychostimulant substrates induce dopamine transporter phosphorylation by a transport and protein kinase C dependent mechanism","author":"Cervinski","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0014-2999(00)00563-X","article-title":"Structure and function of the dopamine transporter","volume":"405","author":"Chen","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/jpet.103.055095","article-title":"Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations","volume":"307","author":"Chi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(99)00828-6","article-title":"Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes","volume":"389","author":"Cowell","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib8","doi-asserted-by":"crossref","first-page":"35794","DOI":"10.1074\/jbc.274.50.35794","article-title":"Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters","volume":"274","author":"Daniels","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1006\/bbrc.2002.6384","article-title":"Cocaine increases dopamine uptake and cell surface expression of dopamine transporters","volume":"290","author":"Daws","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib10","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.105.091231","article-title":"Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909, and benztropine analogues","author":"Desai","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib11","first-page":"312","article-title":"Release of dopamine via the human transporter","volume":"45","author":"Eshleman","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib12","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1060645","article-title":"Dendrodendritic inhibition through reversal of dopamine transport","volume":"293","author":"Falkenburger","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2005.08.011_bib13","doi-asserted-by":"crossref","first-page":"25178","DOI":"10.1074\/jbc.M200294200","article-title":"Dopamine transporters are phosphorylated on N-terminal serines in rat striatum","volume":"277","author":"Foster","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0169-328X(02)00645-9","article-title":"Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1","volume":"110","author":"Foster","year":"2003","journal-title":"Brain Res. Mol. Brain. Res."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib15","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1074\/jbc.M205058200","article-title":"N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization","volume":"278","author":"Granas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib16","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/S0021-9258(17)37256-3","article-title":"Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence","volume":"269","author":"Gu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1471-4159.1997.68010225.x","article-title":"Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax","volume":"68","author":"Huff","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib18","doi-asserted-by":"crossref","DOI":"10.1124\/mol.104.009555","article-title":"Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation","author":"Jayanthi","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib19","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1074\/jbc.M413887200","article-title":"Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta","volume":"280","author":"Johnson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib20","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1073\/pnas.0407737102","article-title":"Amphetamine induces dopamine efflux through a dopamine transporter channel","volume":"102","author":"Kahlig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib21","first-page":"592","article-title":"Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices","volume":"284","author":"Kantor","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib22","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1371\/journal.pbio.0020078","article-title":"N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux","volume":"2","author":"Khoshbouei","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1046-2023(02)00085-3","article-title":"Positron emission tomography: imaging and quantification of neurotransporter availability","volume":"27","author":"Laruelle","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2005.08.011_bib24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1023\/B:NERE.0000026404.08779.43","article-title":"Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter","volume":"29","author":"Lee","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib25","doi-asserted-by":"crossref","first-page":"22168","DOI":"10.1074\/jbc.M301845200","article-title":"The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines","volume":"278","author":"Loder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib26","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1523\/JNEUROSCI.19-18-07699.1999","article-title":"Membrane trafficking regulates the activity of the human dopamine transporter","volume":"19","author":"Melikian","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","article-title":"Dopamine transporters and neuronal injury","volume":"20","author":"Miller","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib28","doi-asserted-by":"crossref","first-page":"C1812","DOI":"10.1152\/ajpcell.2000.279.6.C1812","article-title":"Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells","volume":"279","author":"Nowicki","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib29","first-page":"241","article-title":"Vanoxerine, National Institute on Drug Abuse","volume":"2","author":"Preti","year":"2000","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2005.08.011_bib30","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1073\/pnas.082712899","article-title":"Substrates regulate gamma-aminobutyric acid transporters in a syntaxin 1A-dependent manner","volume":"99","author":"Quick","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.285.5428.763","article-title":"Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants","volume":"285","author":"Ramamoorthy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2005.08.011_bib32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2005.08.011_bib33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1523\/JNEUROSCI.21-04-01413.2001","article-title":"Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model","volume":"21","author":"Sandoval","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.110035297","article-title":"Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism","volume":"97","author":"Saunders","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2005.08.011_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-001-0972-3","article-title":"Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats","volume":"160","author":"Schenk","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.08.011_bib36","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00702-004-0203-2","article-title":"Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration","volume":"111","author":"Storch","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib37","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","article-title":"Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport","volume":"15","author":"Sulzer","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib38","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1523\/JNEUROSCI.23-05-01697.2003","article-title":"A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity","volume":"23","author":"Sung","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib39","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1523\/JNEUROSCI.16-23-07416.1996","article-title":"Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system","volume":"16","author":"Tella","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1124\/jpet.105.085829","article-title":"Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue","volume":"314","author":"Ukairo","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib41","series-title":"Cerebral Signal Transduction: From First to Fourth Messengers","first-page":"375","article-title":"Regulation of the dopamine transporters by phosphorylation and impact on cocaine action. Regulation of dopamine transporter by phosphorylation and impact on cocaine action","author":"Vaughan","year":"2000"},{"key":"10.1016\/j.neuropharm.2005.08.011_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.103.052423","article-title":"Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters","volume":"310","author":"Vaughan","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib43","doi-asserted-by":"crossref","first-page":"21672","DOI":"10.1074\/jbc.271.35.21672","article-title":"Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis","volume":"271","author":"Vaughan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib44","doi-asserted-by":"crossref","first-page":"15541","DOI":"10.1074\/jbc.272.24.15541","article-title":"Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes","volume":"272","author":"Vaughan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2005.08.011_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(01)00158-9","article-title":"Chronic and acute regulation of Na+\/Cl\u2212 -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems","volume":"92","author":"Zahniser","year":"2001","journal-title":"Pharmacol. Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805003151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805003151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:57:39Z","timestamp":1626569859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390805003151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0028390805003151"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2005.08.011","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}